Non-Clinical Topics   /   Pharmacy

New Option Approved for Long-Term COPD Treatment

By U.S. Medicine

RESEARCH TRIANGLE PARK, NC – The Food and Drug Administration has approved the first once-daily, inhaled corticosteroid/long-acting beta2 agonist (ICS/LABA) combination for the long-term, maintenance treatment of airflow obstruction in patients with COPD.

Fluticasone furoate and vilanterol inhalation powder, marketed as Breo Ellipta by GlaxoSmithKline in collaboration with Theravance, contains 100 micrograms fluticasone furoate and 25 micrograms vilanterol administered using Ellipta, a proprietary dry powder inhaler. It also is approved for the reduction of COPD exacerbations in patients with a history of those events.

“COPD is a serious disease that makes breathing difficult,” said Curtis Rosebraugh, MD, MPH, director, Office of Drug Evaluation II, Center for Drug Evaluation and Research at the FDA. “The availability of new long-term maintenance medications provides additional treatment options for the millions of Americans who suffer with COPD.”

FDA said the safety and efficacy of Breo Ellipta were evaluated in 7,700 COPD patients with those treated showing improved lung function and reduced exacerbations compared to placebo.

The drug is not approved for the treatment of asthma. In fact, Breo Ellipta carries a boxed warning that long-acting beta agonists increase the risk of asthma-related death.

It also should not be used as a rescue therapy to treat acute bronchospasm and is not recommended for people younger than 18 years, according to a patient medication guide that accompanies the prescription.

Increased risks of pneumonia and bone fractures are among the most serious side effects of using Breo Ellipta, according to the FDA, with the most common side effects including nasopharyngitis, upper respiratory tract infection, headache and oral candidiasis.


Related Articles

Military E-Prescriptions Exceed 50% Goal Set Three Years Ago

FALLS CHURCH, VA — As of January 2018, 54% of prescriptions filled by MTFs were submitted electronically, exceeding the initial goal of 50% set when the e-prescribing program first rolled out three years ago.

San Diego Revises Alert System in Wake of Administration of Compromised Flu Vaccine

In the fall, failure of a pharmacy refrigerator and its monitoring system resulted in 1,540 veterans and staff receiving potentially ineffective shots.


U.S. Medicine Recommends


More From pharmacy

Pharmacy

Military E-Prescriptions Exceed 50% Goal Set Three Years Ago

FALLS CHURCH, VA — As of January 2018, 54% of prescriptions filled by MTFs were submitted electronically, exceeding the initial goal of 50% set when the e-prescribing program first rolled out three years ago.

Pharmacy

San Diego Revises Alert System in Wake of Administration of Compromised Flu Vaccine

In the fall, failure of a pharmacy refrigerator and its monitoring system resulted in 1,540 veterans and staff receiving potentially ineffective shots.

Pharmacy

Shortage of Supplies Might Have Delayed Medical Procedures at VAMCs

In response to complaints that clinicians at VAMCs lack adequate medical and surgical products to care for veterans, VA conceded it needs to make its product formulary more robust.

Pharmacy

Army Pharmacy Finds Shorter Hours Reduces Wait Times

The pharmacy team at McDonald Army Health Center (MCAHC) on Joint Base Langley-Eustis in Virginia had a common problem—longer than desired wait times for patients to pick up prescriptions.

News

Severe Side Effects Rare in Elderly Veterans Receiving High Dose Influenza Vaccine

Patients over the age of 65 face an increased risk of severe complications and death if they contract influenza.

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up